Exchange: NASDAQ·Updated 07:30 PM EDT

DCTH News

News
all
press releases
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
Zacks
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
Zacks
More News
Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
Teleflex (TFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks
Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?
Veracyte (VCYT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
Are Medical Stocks Lagging Delcath Systems (DCTH) This Year?
Here is how Delcath Systems, Inc. (DCTH) and Encompass Health (EHC) have performed compared to their sector so far this year.
Zacks
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems, Inc. (Nasdaq: DCTH) (the Company or Delcath), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Companys Compensation Committee, as material...
Business Wire
Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services
EuroDry, RCM Technologies, Assembly Biosciences, Delcath Systems and National Energy Services show strong price momentum after August's market gains.
Zacks
Keep Portfolio Volatility in Check With VLO, PBF, FET & DCTH
VLO, PBF, FET and DCTH screen as low-beta picks as volatility rises, backed by refining, energy-equipment and liver-cancer growth drivers.
Zacks
5 Stocks With Recent Price Strength Buoyed by a Strong August
EDRY, RCMT, ASMB, DCTH and NESR show strong recent price momentum after a strong August, backed by improving earnings expectations.
Zacks
Delcath Systems to Participate in Upcoming Investor Conferences
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences:Wells Fargo Healthcare Conference on Thursday, September 10, 2026...
Business Wire
What Makes Delcath Systems, Inc. (DCTH) a Strong Momentum Stock: Buy Now?
Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks

Advertisement|Remove ads.